Problems With Catamaran
Bulls make money, bears make money but pigs get slaughtered, Cramer reminded viewers, as he followed up on SXC Health Solutions, a pharmacy benefit manager he recommended about a year ago. A lot has changed in the year since he made that recommendation, said Cramer, which is why we must revisit this stock.
Cramer said the first thing investors may notice is that SXC Health Solutions no longer exists. The company did a $4.4 billion merger in July and rebranded itself as
. Shares of Catamaran, however, are up 74% since last December.
Catamaran is still a great story, said Cramer. The new company has great scale to compete with the likes of
. There is also a wave of patented drug expirations underway, leaving a wave of generic competion for Catamaran to capitalize on.
But there is a problem, noted Cramer, and that's Catamaran's largest customer,
, which accounts for 10% of the company's earnings. HealthSpring has a contract with Catamaran through 2014, but the status of that contract will be known in January. Since HealthSpring was itself acquired, it may not be renewing its contract.
Cramer said Catamaran can eventually replace these lost earnings with new business, but that won't stop anaylsts from sounding the alarm in the coming weeks -- which is why investors need to sell ahead of that pending news. "Don't give up your gains," Cramer concluded.
In the Lightning Round, Cramer was bullish on
Cramer was bearish on
United States Steel
Cliffs Natural Resources
SandRidge Permian Trust
Digging Into Mine Safety
There's always money to be made speculating on takeovers, Cramer told viewers, but only if it's done wisely. That means never speculating on a company with declining fundamentals.
Fortunately, in the case of
Mine Safety Appliances
(MSA - Get Report)
, makers of safety equipment for miners, oil and gas workers, firemen and those in the construction industry, business is booming.
Cramer said Mine Safety is a classic case of a stock that's unknown and under-covered by Wall Street. He said the company delivered a miss when it last reported, but that was only due to weakness in Europe, which accounts for 24% of the company's sales. As Europe continues to stabilize, Europe will become less of a factor, he said.